Advertisement

Topics

We are attending #ADPD2019 this week alongside international #Alzheimers and Parkinson’s disease researchers. Scientific discussions on AD are crucial to advancing work to #EndAlzpic.twitter.com/bRjBz2L3DK

08:06 EDT 26 Mar 2019 | AztraZeneca

We are attending this week alongside international and Parkinson’s disease researchers. Scientific discussions on AD are crucial to advancing work to

Original Article: We are attending #ADPD2019 this week alongside international #Alzheimers and Parkinson’s disease researchers. Scientific discussions on AD are crucial to advancing work to #EndAlzpic.twitter.com/bRjBz2L3DK

NEXT ARTICLE

More From BioPortfolio on "We are attending #ADPD2019 this week alongside international #Alzheimers and Parkinson’s disease researchers. Scientific discussions on AD are crucial to advancing work to #EndAlzpic.twitter.com/bRjBz2L3DK"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...